SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-006492
Filing Date
2022-02-24
Accepted
2022-02-24 07:11:50
Documents
14
Period of Report
2022-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10034373_8k.htm   iXBRL 8-K 38119
2 EXHIBIT 10.1 brhc10034373_ex10-1.htm EX-10.1 17530
3 EXHIBIT 99.1 brhc10034373_ex99-1.htm EX-99.1 9763
  Complete submission text file 0001140361-22-006492.txt   215376

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aryd-20220223.xsd EX-101.SCH 3941
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aryd-20220223_lab.xml EX-101.LAB 23288
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aryd-20220223_pre.xml EX-101.PRE 16562
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10034373_8k_htm.xml XML 4251
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 212-284-2300
ARYA Sciences Acquisition Corp IV (Filer) CIK: 0001838821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40122 | Film No.: 22666499
SIC: 2836 Biological Products, (No Diagnostic Substances)